CR1, encoding a type-I transmembrane glycoprotein, is one of the most important risk genes for late-onset AD, playing multiple roles in the onset of AD, such as Aβ clearance, neuroinflammation, and tauopathy (Zhu et al., 2015). This evidence concerns the gene CR1 and Alzheimer disease.